Hypogastric Plexus Block and Ganglion Impar Block for Cervical and Endometrial Cancer Pain Management
Recruiting now · Not applicable
Conditions studied: Cervical Cancer, Endometrial Cancer
In brief
This study compared the efficacy and safety of superior hypogastric plexus block and ganglion impar block procedures on the management of pelvic and perineal cancer pain in patients with cervical and endometrial cancer
Key facts
- Study ID
- NCT05427058
- Run by
- University of Brawijaya
- People needed
- 36
- Starts
- 2024-07-23
- Expected to finish
- 2026-01-30
- Last updated by the study team
- 2025-07-10
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Unbearable cancer pain that is resistant to WHO (World Health Organization) pain ladder at least 2 weeks medication
- The patient is tired of taking medication orally or complications of current medication (respiratory depression, nausea, vomiting, opioid-induced constipation, gastrointestinal disturbances)
- Patients with pelvic floor pain diagnosed by a (Fellow of Interventional Pain Practice) FIPP-certified pain specialist
- Patients with pain in the perineum diagnosed by a FIPP-certified pain specialist
- Numerical Rating Scale >4
- >18 years old
- Able and willing to sign an informed consent
You may not qualify if…
- Refuse to be included in the research
- Blood clotting disorders (including taking anticoagulant drugs)
- Local infection in the area of action
- Loss to follow up
- Drop-out Criteria:
- Loss to follow up
- Intervention complications occur
- Failed intervention
Where it is running
- General Hospital Saiful Anwar Malang — Malang, East Java, Indonesia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.